Literature DB >> 769668

Binding of N-substituted erythromycyclamines to ribosomes.

R Vince, D Weiss, S Pestka.   

Abstract

Several N-substituted erythromycylamines were evaluated for their ability to inhibit the binding of [(14)C]erythromycin to ribosomes. The association and dissociation constants for the binding of each compound to Escherichia coli ribosomes were determined. These studies have resulted in the development of three types of probes for topological studies of the erythromycin-binding site and the ribosome: the chemically reactive bromoacetamido, the photoreactive N-(2)-nitro-4-azidophenyl)glycinamido, and the fluorescent fluorescein isothiocyanate derivatives of 9(S)-erythromycylamine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 769668      PMCID: PMC429487          DOI: 10.1128/AAC.9.1.131

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Studies on the formation of transfer ribonucleic acid-ribosome complexes. XXIV. Effects of antibiotics on binding of aminoacyl-oligonucleotides to ribosomes.

Authors:  R Harris; S Pestka
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

2.  Antibacterial activity of 9(S)-erythromycylamine-aldehyde condensation products.

Authors:  E H Massey; B S Kitchell; L D Martin; K Gerzon
Journal:  J Med Chem       Date:  1974-01       Impact factor: 7.446

3.  Erythromycylamine.

Authors:  E H Massey; B Kitchell; L D Martin; K Gerzon; H W Murphy
Journal:  Tetrahedron Lett       Date:  1970-01       Impact factor: 2.415

4.  Correlation of effects of erythromycin analogues on intact bacteria and on [14C]erythromycin binding to Escherichia coli ribosomes.

Authors:  S Pestka; R Lemahieu; P Miller
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

5.  Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes.

Authors:  S Pestka; R A Lemahieu
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

Review 6.  Inhibitors of ribosome functions.

Authors:  S Pestka
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

7.  Binding of [14C]erythromycin to Escherichia coli ribosomes.

Authors:  S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

  7 in total
  5 in total

1.  Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives.

Authors:  S Pestka; R Vince; R LeMahieu; F Weiss; L Fern; J Unowsky
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Fluorescent assay for estimating the binding of erythromycin derivatives to ribosomes.

Authors:  P Brandt-Rauf; R Vince; R LeMahieu; S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

3.  Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.

Authors:  R C Goldman; S K Kadam
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

4.  Ribosome binding by tRNAs with fluorescent labeled 3' termini.

Authors:  B D Wells; C R Cantor
Journal:  Nucleic Acids Res       Date:  1980-07-25       Impact factor: 16.971

5.  Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.

Authors:  R C Goldman; D Zakula; R Flamm; J Beyer; J Capobianco
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.